Pharmacological targeting of eIF4E in primary CLL lymphocytes

por Martinez-Marignac, V, Shawi, M, Pinedo-Carpio, E, Wang, X, Panasci, L, Miller, W, Pettersson, F, Aloyz, R
Publicado 2013

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

por Sahebjam, S, Aloyz, R, Pilavdzic, D, Brisson, M-L, Ferrario, C, Bouganim, N, Cohen, V, Miller, W H, Panasci, L C
Publicado 2011

Double antibody radioimmunoassay for monitoring metastatic breast cancer.

por Schecter, R. L., Major, P. P., Kovac, P. E., Ishida, M., Kovalik, E. C., Dion, A. S., Langleben, A., Boileau, G., Boos, G., Panasci, L.
Publicado 1988